Is Generic Chemotherapy — Actually Safe?

The lower price reflects a difference in cost structure, not in quality. A company that originates a drug spends years and a very large amount of money on research, clinical trials and regulatory submissions — all recovered through the branded price. A generic manufacturer copies a molecule whose patent has expired, does not need to repeat the original clinical trials, and often has lower overheads. Where multiple generic manufacturers compete for the same market, prices fall further still.

Ask your oncology pharmacist to verify the product against the CDSCO drug register, which lists all medicines that have received marketing approval in India. Every approved product should have a CDSCO manufacturing and marketing licence number on its packaging. If a product cannot be verified, raise this with your treating team before it is given. A hospital pharmacy operating under accreditation standards is required to source from licensed manufacturers.

A generic copies a small-molecule drug — a relatively simple chemical that can be reproduced exactly. A biosimilar copies a biological medicine: a large, complex molecule grown in living cells, such as a monoclonal antibody or a growth factor. Because biological molecules are too complex to replicate exactly, biosimilars require separate and more extensive equivalence testing than small-molecule generics. The two terms describe different regulatory categories and should not be used interchangeably.

Yes, because the active molecule is identical. Chemotherapy side effects arise from the molecule acting on rapidly dividing cells, and that mechanism does not change between a branded and a generic version of the same drug. Differences in inactive ingredients rarely affect side effects for intravenous chemotherapy, because the drug enters the bloodstream directly. If you notice any unusual or different reaction after a switch, tell your treating team straightaway.

You can raise the question, and it is a reasonable one. The decision about which approved formulation to use in your regimen is your oncologist's, based on what is available and whether any clinical consideration applies in your specific case. For most standard small-molecule chemotherapy drugs, a branded and a generic version of the same molecule are treated as interchangeable, but the treating team should confirm this before any switch is made.

A legitimately approved generic chemotherapy should show the name of the active ingredient, the dose, batch number, expiry date, the manufacturer's name and address, and a CDSCO manufacturing licence number. If any of these are absent, or if the packaging appears unusual in any way, ask your pharmacist or oncology nurse to verify the product before it is administered. Hospital pharmacies under accreditation standards must source from licensed manufacturers.